Biffi Mauro, Boriani Giuseppe, Bertini Matteo, Silvestri Paolo, Martignani Cristian, Branzi Angelo
Institute of Cardiology, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Europace. 2005 May;7(3):255-65. doi: 10.1016/j.eupc.2005.01.007.
Devices for cardiac resynchronisation therapy (CRT) deliver energy into 3 output channels. Such a burden can significantly reduce device longevity. Autocapture has been shown to improve pacemaker longevity and safety of right ventricular pacing in clinical studies. The aim of this study was to investigate the application of Autocapture during biventricular pacing (BIV) to decrease the energy cost of CRT.
During implantation of BIV devices, an acute study was performed to test the hypothesis that the evoked response (ER) elicited by each delivered stimulus is correctly detected and measured either on the right ventricular (RV) channel during BIV pacing with the left ventricular (LV) channel pacing first, or in the LV channel with the RV channel pacing first. A reliable measurement of ER is the critical requirement for the correct performance of Autocapture.
ER amplitude in the right ventricle during BIV pacing was not significantly decreased compared with RV pacing in the VVI mode (16.36+/-5.27 mV vs 17.09+/-6.12 mV). ER amplitude in the left ventricle during BIV pacing was not significantly decreased compared with LV pacing in the VVI mode (12.4+/-8.95 mV vs 12.25+/-8.97 mV). Three patients in atrial fibrillation had a DDDR pacemaker with the LV lead connected to the atrial port, and received BIV pacing with Autocapture turned on in the RV channel. Autocapture performance in the long term, as assessed by the trend of RV threshold over 20+/-8 months, showed that LV depolarisation was never sensed as an ER on the RV channel.
Our observations support the feasibility and safety of capture verification during BIV pacing on the ventricular channel paced secondly, which could increase the longevity of CRT devices, and decrease the costs of this new therapy for heart failure patients.
心脏再同步治疗(CRT)设备通过3个输出通道输送能量。如此大的负担会显著缩短设备使用寿命。临床研究表明,自动夺获功能可提高起搏器的使用寿命以及右心室起搏的安全性。本研究旨在探讨自动夺获功能在双心室起搏(BIV)中的应用,以降低CRT的能量消耗。
在植入BIV设备期间,进行了一项急性研究,以检验以下假设:在左心室(LV)通道先起搏的BIV起搏过程中,在右心室(RV)通道上能正确检测和测量每次输送刺激引发的诱发反应(ER);或者在右心室通道先起搏的情况下,在左心室通道上能正确检测和测量ER。对ER进行可靠测量是自动夺获功能正确运行的关键要求。
与VVI模式下的右心室起搏相比,BIV起搏期间右心室的ER幅度未显著降低(16.36±5.27 mV对17.09±6.12 mV)。与VVI模式下的左心室起搏相比,BIV起搏期间左心室的ER幅度未显著降低(12.4±8.95 mV对12.25±8.97 mV)。3例心房颤动患者植入了DDDR起搏器,左心室导线连接到心房端口,并在右心室通道开启自动夺获功能的情况下接受BIV起搏。通过右心室阈值在20±8个月内的变化趋势评估的长期自动夺获功能表现表明,左心室去极化从未在右心室通道上被感知为ER。
我们的观察结果支持在第二个起搏的心室通道上进行BIV起搏时进行夺获验证的可行性和安全性,这可以延长CRT设备的使用寿命,并降低这种针对心力衰竭患者的新疗法的成本。